A simple and improved routine praparation of no-carrier-added meta I- 123- and I-131-iodobenzylguanidine (I-123-MIBG and I-131-MIBG) for clinical nuclear medicine applications;Einfache und schnelle routineherstellung von ungetragertem meta-I-123- und I-131-iodbenzylguanidin (I-123-MIBG und I-131-MIBG) fur die klinischen nuklearmedizinischen anwendungen

NuklearMedizin

Volumn 38, Issue 7, 1999, Pages 292-296

  Samnick, Samuel ^a   Kirsch, C M ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

Clinical routine; N.c.a. I 123 MIBG and I 131 MIBG; Radioiodination; I 123 I 131 iododebromination

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; (3 IODOBENZYL)GUANIDINE I 131; DRUG CARRIER;

ARTICLE; DEBROMINATION; DIAGNOSTIC VALUE; DRUG ACTIVITY; DRUG PURIFICATION; DRUG PURITY; DRUG SAFETY; DRUG STERILITY; DRUG STRUCTURE; DRUG SYNTHESIS; HEART DISEASE; NEUROENDOCRINE TUMOR; RADIOIODINATION; REACTION TIME;

EID: 0032724934     PISSN: 00295566     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0038-1632223     Document Type: Article

References (28)

1. Beierwaltes WH. Uptake on basic research and clinical experience with meta-iodobenzyl-guanidine. Med Ped Oncol 1987; 15: 163-7.
2. Troncone L, Rufini V, Montemaggi P et al. The diagnostic and therapeutic utility of radioiodinated meta-iodobenzylguanidine (MIBG): 5 years experience. Eur J Nucl Med 1990; 16: 325-31.
3. Merlet P, Valette H, Dubois-Rande JL et al. Prognostic value of cardiac meta-iodobenzylguanidine imaging in patients with heart failure. J Nucl Med 1992; 33: 471-7.
4. Schaefers M, Schober O, and Lerch H. Cardiac Sympathetic neurotransmission scintigraphy. Eur. J. Nucl. Med. 1998; 25: 435-41.
5. Takeishi Y, Atsumi H, Fujiwara S et al. ACE inhibition reduces cardiac iodine-123-MIBG release in heart failure. J Nucl Med 1997; 38: 457-9.
6. Abe Y, Sugiura T, Suga Y et al. Serial assessment of sympathetic reinnervation in a patient with myocardial infarction. J Nucl Med 1997; 38: 1085-9.
7. 123I-MIBG) in patients with myocardial infarct. J Nucl Med 1989; 15: 624-8.
8. Lerch H, Wichter T, Schamberger R et al. Sympathetic myocardial innervation in idiopathic ventricular tachycardia and fibrillation. Eur J Nucl Med 1995; 22, 805.
9. Gohl K, Feistel H, Weikl A et al. Congenital myocardial sympathetic dysinnervation (CMSD) - a structural defect of idiopathic long QT syndrome. Pacing Clin Electrophysiol 1991; 14: 1544-53.
10. Schnell O, Kirsch CM, Stemplinger J et al. Scintigraphic evidence for cardiac sympathetic dysinnervation in long-term IDDM patients with and without ECG-based autonomic neuropathiy. Diabetologia 1995; 38: 1345-52.
11. Agostini D, Babatasi G, Manrique A et al. Impairment of cardiac neuronal function in acute myocarditis: Iodine-123-MIBG scintigraphy study. J Nucl Med 1998; 39: 1841-4.
12. Toba M, Ishida Y, Fukuchi K et al. Sympathetic Reinnervation demonstrated on serial Iodine-123-metaiodobenzylguanidine SPECT images after cardiac transplantation. J Nucl Med 1998; 39: 1862-4.
13. Jonas M, Kerstin K, Sciuk J et al. I-123-MIBG-Szintigraphie: Nachweis einer partiellen Reinnervation bei herztransplantierten Patienten. Nuklearmedizin 1997; 36: A64.
14. 123I-mIBG in rats. Nucl Med Commun 1988; 9: 663-7.
15. Mairs RJ, Cunningham SH, Russell J et al. No-Carrier-Added Iodine-131-MIBG: Evaluation of a therapeutic preparation. J Nucl Med 1995; 36: 1088-95.
16. Farahati J, Dutschka K, Stüben G et al. The effect of specific activity on I-123-MIBG uptake in SK-N-SK tumor cells in a xenograft nude mouse model. Eur J Nucl Med 1995; 22: 829.
17. Tamaki N. Imaging of cardiac neuronal and receptor function. J Nucl Cardiol 1997; 4: 553-4.
18. Visser GM, van Waarde A, van der Mark TW et al. Characterization of Pulmonary and Myocardial Beta-Adrenoceptors with S-1'-[Fluorine-18]Fluorocarazolol. J Nucl Med 1997; 38: 169-74.
19. 123I] MIBG und verbesserte Darstellung der sympathischen Innervation bei Patienten mit therapie-refraktären Kammertachykardien. Nuklearmedizin 1998; 37: A52.
20. 131I]MIBG-Uptake in Pheochromocytoma. Eur J Nucl Med 1998; 25: 1132.
21. 123I]iodobenzylguanidine and preliminary clinical evaluation in patients with ventricular arrhythmias. Nucl Med Commun 1999 (In press).
22. Vaidyanathan G, Zalutsky MR. No-carrier-added meta-iodobenzylguanidine: synthesis and preliminary evaluation. Nucl Med Biol 1995; 22: 61-4.
23. 131I-meta-iodobenzylguanidine: comparison of production from meta-diazobenzylguanidine and from meta-trimethylsilylbenzylguanidine. Nucl Med Commun 1994; 15: 268-74.
24. Moerlein SM. Regiospecific aromatic radioiodination via no-carrier-added copper(I)-chloride assisted iododebromination. Radiochim Acta 1990; 50: 55-61.
25. 123I]Iodphenyl)tropan-2ß-carbonsäuremethylester durch nicht-isotopen, Cu(I)-assistierten Halogenaustausch. Nuklearmedizin 1994; 33: A11.
26. 131I]Iodobenzylguanidine. J Nucl Med 1980; 21: 349-53.
27. Valette H, Loc'h C, Mardon K et al. Bromine-76-metabromobenzylguanidine: a PET radiotracer for mapping sympathetic nerves of the heart. J Nucl Med 1993; 34: 1739-44.
28. Farahati J, Bier D, Scheubeck M et al. Effect of specific activity on cardiac uptake of Iodine-123-MIBG.J Nucl Med 1997; 38: 447-51.